Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
出版年份 2020 全文链接
标题
Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 10, Issue 1, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-12-17
DOI
10.1161/jaha.120.018184
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
- (2019) Michael S. Conte et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
- (2019) Kazunori Toyoda et al. LANCET NEUROLOGY
- Progress in the Mechanism and Clinical Application of Cilostazol
- (2019) Huilei Zheng et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- How To Assess a Claudication and When To Intervene
- (2019) Prio Hossain et al. Current Cardiology Reports
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity
- (2018) Yi-Da Tang et al. CIRCULATION
- Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction ― The CALDERA-GENE Study ―
- (2018) Koichi Kaikita et al. CIRCULATION JOURNAL
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
- (2017) Victor Aboyans et al. EUROPEAN HEART JOURNAL
- Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting
- (2017) Ichiro Nakagawa et al. NEUROLOGICAL RESEARCH
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- (2016) Marie D. Gerhard-Herman et al. CIRCULATION
- Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
- (2016) Peng-Peng Niu et al. BMJ Open
- Prevention of Femoropopliteal In-Stent Restenosis With Cilostazol
- (2015) Omer Iftikhar et al. ANGIOLOGY
- A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease
- (2015) Smriti Krishna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
- (2015) Konstantinos Katsanos et al. PLoS One
- Is it a stroke?
- (2015) G. J. Hankey et al. BMJ-British Medical Journal
- Is it a stroke?
- (2015) G. J. Hankey et al. BMJ-British Medical Journal
- Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes: Results From the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial
- (2014) Andrew D. Althouse et al. DIABETES CARE
- Diffusion-weighted imaging and diagnosis of transient ischemic attack
- (2013) Miriam Brazzelli et al. ANNALS OF NEUROLOGY
- Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons
- (2013) Yu Chen et al. CURRENT MEDICAL RESEARCH AND OPINION
- Revisiting the links between glycaemia, diabetes and cardiovascular disease
- (2013) N. Sattar DIABETOLOGIA
- Diagnostic Value of Ankle-Brachial Index in Peripheral Arterial Disease: A Meta-analysis
- (2012) Dachun Xu et al. CANADIAN JOURNAL OF CARDIOLOGY
- Antiplatelet Drugs
- (2012) John W. Eikelboom et al. CHEST
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. CIRCULATION
- Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives
- (2012) Kallirroi I Kalantzi et al. Expert Review of Clinical Pharmacology
- Anti-platelet therapy: phosphodiesterase inhibitors
- (2011) Paolo Gresele et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Is Hyperglycemia a Cardiovascular Risk Factor?
- (2011) F. Pistrosch et al. DIABETES CARE
- The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment
- (2011) Kallirroi I. Kalantzi et al. PLATELETS
- Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
- (2011) Dominick J. Angiolillo et al. THROMBOSIS AND HAEMOSTASIS
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
- (2010) Yukito Shinohara et al. LANCET NEUROLOGY
- Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention
- (2008) Boris Aleil et al. JACC-Cardiovascular Interventions
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started